Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis.

Jiang H, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B, Jiang Q, Chen H, Chen YH, Han W, Zhang XH, Wang Y, Wang JZ, Wang FR, Qin YZ, Lai YY, Huang XJ.

Bone Marrow Transplant. 2014 Sep;49(9):1146-54. doi: 10.1038/bmt.2014.146.

PMID:
25046218
2.

Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.

Xu L, Zhu H, Hu J, Wu D, Jiang H, Jiang Q, Huang X.

Front Med. 2015 Sep;9(3):304-11. doi: 10.1007/s11684-015-0400-4.

PMID:
26100855
3.

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.

Nair AP, Barnett MJ, Broady RC, Hogge DE, Song KW, Toze CL, Nantel SH, Power MM, Sutherland HJ, Nevill TJ, Abou Mourad Y, Narayanan S, Gerrie AS, Forrest DL.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1437-44. doi: 10.1016/j.bbmt.2015.04.005.

4.

[Outcomes of imatinib and allogeneic hematopoietic stem cell transplantation in the treatment of chronic myeloid leukemia].

Zhou M, Sha X, Qiu H, He G, Xu Y, Cen J, Pan J, Chen S, Sun A, Zhang R, Wu D.

Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):126-8. doi: 10.3760/cma.j.issn.0253-2727.2014.02.014. Chinese.

PMID:
24606653
5.

Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.

Chamseddine AN, Willekens C, De Botton S, Bourhis JH.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S129-40. doi: 10.1016/j.clml.2015.05.001.

PMID:
26297265
6.

Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.

Wright MP, Shepherd JD, Barnett MJ, Nantel SH, Sutherland HJ, Toze CL, Hogge DE, Nevill TJ, Song KW, Abou Mourad YR, Narayanan S, Power MM, Smith CA, Forrest DL.

Biol Blood Marrow Transplant. 2010 May;16(5):639-46. doi: 10.1016/j.bbmt.2009.11.026.

7.

A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation.

Shanavas M, Messner HA, Kamel-Reid S, Atenafu EG, Gupta V, Kuruvilla J, Kim DD, Uhm J, Lambie A, Ellis L, Lipton JH.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):87-92. doi: 10.1016/j.clml.2013.09.010.

PMID:
24252361
8.

Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.

Yong AS, Brissot E, Rubinstein S, Savani BN, Mohty M.

Expert Rev Hematol. 2015 Dec;8(6):785-97. doi: 10.1586/17474086.2015.1087843. Review.

PMID:
26364871
9.

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.

Ferri C, Bianchini M, Bengió R, Larripa I.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):121-5. doi: 10.1016/j.bcmd.2013.09.002.

PMID:
24091144
10.

Management of chronic myeloid leukemia in blast crisis.

Saußele S, Silver RT.

Ann Hematol. 2015 Apr;94 Suppl 2:S159-65. doi: 10.1007/s00277-015-2324-0. Review.

PMID:
25814082
11.

Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors.

Champlin R, Jabbour E, Kebriaei P, Anderlini P, Andersson B, de Lima M.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S96-100. doi: 10.1016/j.clml.2011.03.028.

12.

[Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase].

Gao GL, Xu N, Zhou X, Xiao YJ, Ding L, Lu QS, Wei YQ, Zhang Y, Xu D, Sun J, Liu QF, Liu XL.

Zhonghua Yi Xue Za Zhi. 2013 Oct 15;93(38):3035-9. Chinese.

PMID:
24417923
13.

Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib.

Breccia M, Palandri F, Iori AP, Colaci E, Latagliata R, Castagnetti F, Torelli GF, Usai S, Valle V, Martinelli G, Rosti G, Foà R, Baccarani M, Alimena G.

Leuk Res. 2010 Feb;34(2):143-7. doi: 10.1016/j.leukres.2009.04.036.

PMID:
19481800
14.

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Ruiz-Argüelles GJ, Tarin-Arzaga LC, Gonzalez-Carrillo ML, Gutierrez-Riveroll KI, Rangel-Malo R, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Gómez-Almaguer D, Giralt S.

Bone Marrow Transplant. 2008 Jul;42(1):23-8. doi: 10.1038/bmt.2008.90.

PMID:
18612313
15.

Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

Oyekunle A, Zander AR, Binder M, Ayuk F, Zabelina T, Christopeit M, Stübig T, Alchalby H, Schafhausen P, Lellek H, Wolschke C, Müller I, Bacher U, Kröger N.

Ann Hematol. 2013 Apr;92(4):487-96. doi: 10.1007/s00277-012-1650-8.

PMID:
23250623
16.

Chronic myeloid leukemia-transplantation in the tyrosine kinase era.

Innes AJ, Apperley JF.

Hematol Oncol Clin North Am. 2014 Dec;28(6):1037-53. doi: 10.1016/j.hoc.2014.08.002. Review.

PMID:
25459178
17.

Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.

Boehm A, Walcherberger B, Sperr WR, Wöhrer S, Dieckmann K, Rosenmayr A, Pernicka E, Fischer G, Worel N, Mitterbauer G, Schwarzinger I, Mitterbauer M, Haas OA, Lechner K, Hinterberger W, Valent P, Greinix HT, Rabitsch W, Kalhs P.

Biol Blood Marrow Transplant. 2011 Jan;17(1):133-40. doi: 10.1016/j.bbmt.2010.06.019.

18.

Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Byeun JY, Park JE, Jeon HR, Oh YJ, Yahng SA, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Lee JW, Min WS, Park CW, Kim DW.

Hematology. 2014 Mar;19(2):63-72. doi: 10.1179/1607845413Y.0000000100.

PMID:
23684143
19.

Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.

Poiré X, Artz A, Larson RA, Kline J, Odenike O, Rich E, Godley L, Stock W, van Besien K.

Leuk Lymphoma. 2009 Jan;50(1):85-91. doi: 10.1080/10428190802626624.

20.

Current role of stem cell transplantation in chronic myeloid leukaemia.

Gratwohl A, Heim D.

Best Pract Res Clin Haematol. 2009 Sep;22(3):431-43. doi: 10.1016/j.beha.2009.05.002. Review.

PMID:
19959092
Items per page

Supplemental Content

Support Center